PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Nasim Bahar,
Leyla Mohseninejad,
Keltie Mcdonald,
Thomas Wilke
Affiliations
Nasim Bahar
1 BeiGene Switzerland GmbH, HEOR (Global and Europe), Basel, Switzerland
Leyla Mohseninejad
1 BeiGene Switzerland GmbH, HEOR (Global and Europe), Basel, Switzerland
Keltie Mcdonald
2 Cytel Inc, Waltham, United States
Thomas Wilke
3 Affiliated institute of the University of Wismar, Institut für Pharmakoökonomie und Arzneimittellogistik, Germany